Analysts expect Transcode Therapeutics, Inc. to report revenue of 280,144.50 for Q4 24, against a range of 268,463.31 to 291,825.69. The most recent reported quarter, Q3 24, came in at 0.00, a 100.0% miss against the 309,588.00 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | - | - | - | - | - | - | - | - | |||||||||||||||||
| High Estimate | 0.00 | 329,297.30 | 291,825.69 | 0.00 | 0.00 | 0.00 | 0.00 | 56,720.55 | 139,901.45 | 173,626.64 | |||||||||||||||||
| Low Estimate | 0.00 | 289,878.70 | 268,463.31 | 0.00 | 0.00 | 0.00 | 0.00 | 50,196.07 | 130,341.35 | 151,507.44 | |||||||||||||||||
| Consensus Estimate | 0.00 | 309,588.00 | 280,144.50 | 0.00 | 0.00 | 0.00 | 0.00 | 53,458.31 | 135,121.40 | 162,567.04 |
Analysts expect Transcode Therapeutics, Inc. to report earnings per share of -3,141.43 for Q4 24, against a range of -3,443.90 to -2,838.96. The most recent reported quarter, Q2 26, came in at -7.17, a 163.6% miss against the 11.28 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -600.60 | -683.76 | -147.84 | - | -2.51 | -5.13 | -5.82 | -21.83 | -21.28 | -7.17 | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -661.38 | -480.92 | -437.95 | -2,838.96 | -55.04 | -8.09 | -8.01 | -9.89 | 688.43 | 11.75 | -216.89 | -414.94 | 937.78 | 128.37 | -280.30 | -647.20 | 980.84 | |||||||||||
| Low Estimate | -722.34 | -528.30 | -530.85 | -3,443.90 | -63.04 | -9.71 | -9.55 | -10.91 | 636.51 | 10.81 | -236.65 | -443.96 | 860.04 | 113.81 | -324.16 | -688.42 | 803.46 | |||||||||||
| Consensus Estimate | -691.86 | -504.61 | -484.40 | -3,141.43 | -59.04 | -8.90 | -8.78 | -10.40 | 662.47 | 11.28 | -226.77 | -429.45 | 898.91 | 121.09 | -302.23 | -667.81 | 892.15 |
Pull Wall Street consensus for Transcode Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RNAZ&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RNAZ", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RNAZ&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();